Methods and compositions for treating psychiatric diseases and disorders
are disclosed. The methods provided generally involve the administration
of an amylin or an amylin agonist to a subject in order to treat
psychiatric diseases and disorders, and conditions associated with
psychiatric diseases and disorders.